COMPANY · NIPC 980553768

Alexion Pharma Spain, S.L - Sucursal em Portugal

This page shows the public contracts the company has signed, which bodies gave them, and who it competed against.

Portal BASE records €97,470,086.60 across 330 contracts.

Follow (RSS) · What is RSS?

Identification

Company nameAlexion Pharma Spain, S.L - Sucursal em Portugal
NIPC980553768
Registered officeAvenida António Augusto de Aguiar, nº 19, 4º, sala B, 1050-012 Lisboa
SourceTED (Jornal Oficial da UE), aviso 483223-2025
Record date24 July 2025

Contracted money

Sums of the contract prices on Portal BASE. A contract with several buyers or municipalities counts once in each row, so rows do not add up to the total.

Contracted value by yearBars with the value contracted in each year, from 2018 to 2026. The table below gives the same values.2018: €1,516,595.9020182019: €5,342,560.982020: €4,584,258.2420202021: €11,681,484.422022: €11,186,143.1720222023: €14,760,812.932024: €15,847,901.7920242025: €18,408,513.172026: €14,141,8162026€18,408,513.17
Contracted value by year
YearContractsContract value
201815€1,516,595.90
201940€5,342,560.98
202027€4,584,258.24
202152€11,681,484.42
202239€11,186,143.17
202351€14,760,812.93
202443€15,847,901.79
202538€18,408,513.17
202625€14,141,816
Contracted value by place of performance
NameContractsContract value
Lisboa81€46,798,214.22
Porto88€15,426,389.54
Coimbra23€8,875,048.33
Funchal19€5,848,985.63
Vila Nova de Gaia5€3,025,061.92
Braga16€2,712,759.95
Guimarães5€2,344,692.44
Amadora9€2,031,823.50
Setúbal31€2,031,778.08
Faro6€1,294,786
Largest contracts
SubjectYearContract value
EX /1315/2025- SELUTINIB 10 E 25 MG2025€5,689,980
EXCLUSIVOS ALEXION2026€3,922,640.62
AJUSTE DIRETO PARA A AQUISIÇÃO DE E375 - ECULIZUMAB [300 MG; SOL INJ; FRS] PARA SUPRIR NECESSIDADES PARA O CENTRO HOSPITALAR UNIVERSITÁRIO LISBOA NORTE E.P.E. PARA O TRIÉNIO 2022-2024.2022€2,943,454.16
EX/529/2025-SELUMETINIB 10MG CP/ SELUMETINIB 25MG CP2025€2,350,008
Ajuste direto para aquisição de Eculizumab [300 mg; sol inj; frs], para suprir necessidades na área da saúde2024€1,843,927.20

Who they competed with

In 73 contracts with a list of competitors, the company took part and was awarded 71 (97%).

Companies with the most procedures in common
CompanyProcedures in common
AMGEN BIOFARMACÊUTICA, LDA.1

The annual IMPIC file lists competitors for about 42% of contracts. Only these enter the counts, and the award share is measured on them.

Links read in contract documents

Contract documents give addresses and the names of representatives and partners, and Portal BASE and GLEIF give competitors and groups. This is what the records show; the same address or name can have simple explanations.

Links read in contract documents32 companies and 31 links. The list below gives the same content as text.NIPC 500048193 (NIPC 500048193)NIPC 500048193NIPC 500063524 (NIPC 500063524)NIPC 500063524NIPC 500101965 (NIPC 500101965)NIPC 500101965NIPC 500134960 (NIPC 500134960)NIPC 500134960NIPC 500139962 (NIPC 500139962)NIPC 500139962NIPC 500162166 (NIPC 500162166)NIPC 500162166NIPC 500165602 (NIPC 500165602)NIPC 500165602NIPC 500189412 (NIPC 500189412)NIPC 500189412NIPC 500230366 (NIPC 500230366)NIPC 500230366NIPC 500233810 (NIPC 500233810)NIPC 500233810Alexion Pharma Spain, S.L… (NIPC 980553768)Alexion Pharma Spain, S.L…+21 in the list below

Dotted: competed in the same procedure. Dotted: same procedure.

19 more links

Investigations that mention it

No published investigation mentions this company by NIPC.